Somnidren-GH FAQ's
Somnidren-GH FAQ’s!
Q: Why is Somnidren-GH™ so effective?
A: Somnidren-GH is super concentrated and unadulterated allowing for maximum synergy between the ingredients. Unlike most growth hormone products Somnidren-GH™ synergistically addresses the most important aspects of growth hormone release and sustain. Most GH products on the market usually only address one aspect of GH release and try to beef up their serving size with maltodextrin or other carbohydrate which is detrimental to the release of GH.
Q: Is it really necessary to take Somnidren-GH on an empty stomach?
A: YES! We recommend taking Somnidren-GH at least 2 hours after your last meal for best results. Any insulin or excess lipids in your blood steam will negate a maximal GH release. You will find that your night time casein protein right before bed is not needed to maintain an anabolic environment. In fact food consumed right before bedtime regardless of source usually negates growth hormone completely for a period of time and is most likely slowing your repair and growth down. Tip: You will find that time released proteins are far more effective when taken at least 2 hours before bedtime when using Somnidren-GH than when taken alone right before retiring. Somnidren-GH is much more effective and will yield greater results when taken on an empty stomach. It’s the hormonally correct thing to do. Don’t believe the myth that you have to consume food or protein right before bed to stay anabolic and grow. Growth hormone prevents catabolism and promotes anabolism while you sleep, not protein.
Q: Is Somnidren-GH™ safe?
A: Yes, as long as you use it as directed, read all of the warnings prior to use and are not excluded from use by any item stated in the warning.
Q: Is Somnidren-GH™ safe for long term use?
A: Yes! But, we recommend taking Somnidren-GH™ for 20 nights on and 5-7 nights off to avoid building tolerance or negative feedback loop interference. By cycling Somnidren-GH™ in this manor you ensure that you reap the benefits without the product becoming less effective over time due to down regulation of receptor sites. Some find it effective to use a 5 nights on and 2 nights off protocol.
Q: Is Somnidren-GH™ natural?
A: Yes! Somnidren-GH™ is comprised of natural ingredients and contains zero artificial colors, preservatives or sweeteners like aspartame or ace-k. Somnidren-GH™ uses minimal amounts of stevia and xylitol for sweeteners and contains less than 2 tenths of one percent of sucralose per serving to smooth the flavor out. Most popular HGH products contain maltodextrin, aspartame and artificial colors and preservatives, but NOT Somnidren-GH™.
Q: Who can use Somnidren-GH™?
A: Anyone who needs to support sleep, recovery, lean mass growth or fat loss. We recommend that Somnidren-GH™ is used only by healthy adults over the age of 18.
Q: Who Should NOT use Somnidren-GH™?
A: Somnidren-GH™ should NOT be used by anyone who suffers from sleep apnea, narcolepsy or any related sleep disorder, any mental illness including bipolar disorder, alcohol or drug dependency or by individuals who are currently taking prescription or over the counter medication including but not limited to opiates or opiate derivatives, sleep aids, other GABA supplements, MAO inhibitors, SSRI or any other anti-depressant, alcohol or recreational drugs.
Q: When is the most effective time to take Somnidren-GH™?
A: Take Somnidren-GH™ 30-60 minutes prior to bed time when you can commit 7-8 hours to sleep. Somnidren-GH™ may also be taken in smaller doses during the day to enhance GH release and combat stress and anxiety. NOTE: Never take Somnidren-GH if there is a chance that you will be driving a motor vehicle or operating machinery or heavy equipment within 7-8 hours as your reflexes may be slowed or impaired.
Q: What are the side effects from Somnidren-GH™?
A: Shortly after consumption some individuals may experience a tingling or flushing sensation which is normal and subsides after 10-15 minutes. Some people experience a heavy feeling accompanied by changes in respiration (deeper breathing), this effect is normal and subsides in 2-10 minutes for most. Some users may experience drowsiness upon wakening especially if enough time wasn’t devoted to sleep. Note: Some individuals may experience a short period of energy (15-60 minutes) before Somnidren-GH™’s full effects kick in. This is uncommon, but a normal effect for few.
Q: Can I take more than one serving before bed?
A: Yes. Some people over 200 pounds may find it beneficial to take one and a half to two servings prior to bed. This is not needed for the majority as one serving is sufficient. Do not take more than two servings in a 24 hour period.
Q: Can I stack Somnidren-GH™ with any other night time products?
A: Somnidren-GH™ may be stacked with ZMK™ since they work on separate pathways and compliment one another very well. Some people find this stack very strong so assess the stacked dose one night at a time before increasing. The addition of ZMK will further enhance sleep, testosterone and IGF-1 levels leading to enhanced recovery.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, prevent or cure any disease.
References: Effect of acute and repeated administration of gamma aminobutyric acid (GABA) on growth hormone and prolactin secretion in man. Acta Endicrinol (Copenhagen) 1980, Feb-93(2):149-54 Effect of gamma-aminobutyric acid on growth hormone and prolactin secretion in man: influence of pimozide and domperidone. First Medical Clinic at the University of Milan in Milan, Italy /J Clin Endocinol Metab 1980 Oct:51(4):789-92 Strobl JS, Thomas MJ. Human growth hormone. Pharmacol Rev. 1994 Mar;46(1):1–34 Delitala G, Tomasi P, Virdis R. Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications. J Endocrinol Invest. 1988 Jun;11(6):441–462 Hindmarsh PC, Brain CE, Robinson IC, Matthews DR, Brook CG. The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man. Clin Endocrinol (Oxf). 1991 Oct;35(4):353–360. Clark RG, Carlsson LM, Rafferty B, Robinson IC. The rebound release of growth hormone (GH) following somatostatin infusion in rats involves hypothalamic GH-releasing factor release. J Endocrinol. 1988 Dec;119(3):397–404 Jaffe CA, Friberg RD, Barkan AL. Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses. J Clin Invest. 1993 Aug;92(2):695–701 Chihara K, Kashio Y, Kita T, Okimura Y, Kaji H, Abe H, Fujita T. L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans. J Clin Endocrinol Metab. 1986 Mar;62(3):466–473 Richardson SB, Hollander CS, D'Eletto R, Greenleaf PW, Thaw C. Acetylcholine inhibits the release of somatostatin from rat hypothalamus in vitro. Endocrinology. 1980 Jul;107(1):122–129. Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men. J Clin Endocrinol Metab. 1991 Aug;73(2):251–256. Masuda A, Shibasaki T, Hotta M, Yamauchi N, Ling N, Demura H, Shizume K. Insulin-induced hypoglycemia, L-dopa and arginine stimulate GH secretion through different mechanisms in man. Regul Pept. 1990 Oct 29;31(1):53–64. Yokogoshi H, Mochizuki M, and Saitoh K, Theanine-induced reduction of brain serotonin concentration in rats, Bioscience, Biotechnology, and Biochemistry 1998; 62(4): 816-817. Yokogoshi H, et al., Effect of theanine on brain monoamines and striatal dopa-mine release in conscious rats, Neurochemical Research 1998; 23(5): 667-673. Yokogoshi H, and Terashima T, Effect of theanine on brain monoamines, striatal, dopamine release and some kinds of behavior in rats, Nutrition 2000; 16(9): 776-777. Kobayashi K, et al., Effects of l-theanine on the release of alpha-brain waves in human volunteers, Nippon Noegikagako Kaishi 1998; 72 (2): 153-157.
